|
Symposium
[Free Online] Innovative Life Science Technologies in the Drug Development Toolbox: From Cancer Organoids and Biomarker Profiling to Label-Free Multiplex QES Assays
Speakers:
Aihua Fu, NVIGEN; Emily Miyashita-Lin, Cellentia; Chaitanya Gupta, Probius; Joseph de Rutte, Partillion Bioscience; Andrew Chang, DeepSeq.AI; Xiaoxi Wei, X-Therma Inc.; Samuel Tia, Correlia Biosystems
Organizers:
Shian Jiun Shih (Cellentia, Inc.), Aihua Fu (NVIGEN), Alex Yang (Vir Biotechnology)
Date:
2024-04-12
Time:
8:30-13:30 Pacific Time
Registration fee:
0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-04-11
(it will close sooner if the seating cap is reached)
About the Topic
The abstract of this symposium:
The era of one-size-fits-all pharmaceuticals is fading. Today, the drug development landscape brims with groundbreaking modalities - from gene and cell therapies to mRNA and antibody-drug conjugates (ADCs) armed with radiotherapy. This transformative journey demands equally disruptive tools to streamline and accelerate research. Join us at this symposium as we explore the frontier of technology propelling the discovery of next-generation therapeutics. This symposium will showcase a diverse arsenal of tools designed to empower every stage of drug development. Topics include single-cell analysis, AI-based protein design, cancer organoids for drug screening, multiplex assays sans detecting agents, and sensitive NGS/multiomic biomarker profiling assays revealing previously hidden disease complexity. These advancements reflect the continuous pursuit of innovation, accelerating the quest for more effective, targeted, and ultimately, transformative therapeutic solutions.
Time (PT)
|
Topic
|
Speaker
|
8:30-8:40 am
|
PBSS Welcome and Introduction
|
Shichang Miao, PhD, PBSS
|
8:40-9:15 am
|
Novel Non-Invasive Organoid Platform from Cancer Patient Circulating Tumor Cells for Drug Screening and Monitoring
|
Emily Miyashita-Lin, Director, Cellentia
|
9:15-9:50 am
|
Expand Your Functional Toolkit: Nanovial Assays for Drug Discovery and Development
|
Joseph De Rutte, CEO and Co-founder, Partillion Bioscience
|
9:50-10:25 am
|
Evaluation of the PIXI™ Automated Platform for Rapid, Micro-volume PK Measurements
|
Samuel Tia, CSO and Co-founder, Correlia Biosystems
|
10:25-10:35 am
|
Break
|
-
|
10:35-11:10 am
|
Crack the Biomarker Code: Accelerate Drug Development with NVIGEN's Precision Medicine Biomarker Profiling Assays
|
Aihua Fu, CEO and Co-founder, NVIGEN
|
11:10-11:45 am
|
Simplifying Bio Analytical Assay Development: The Quantum Electrochemical Spectroscopy (QES) Approach
|
Chaitanya Gupta, CTO and Co-founder, Probius
|
11:45-12:20 pm
|
A Tale of a Golden Shovel in the Gold Rush: Next-Generation DMSO-Free & Serum-Free Biopreservation for Cell & Gene Therapies and Engineered Tissues Manufacturing And Processing
|
Xiaoxi (Sofie) Wei,CEO and Co-founder, X-Therma
|
12:20-12:55 pm
|
Unlocking the Potential of Explainable AI in Designing Functional Protein Libraries
|
Andrew Chang,CEO and Co-founder, DeepSeq AI
|
12:55-1:25 pm
|
Q&A and Panel discussion
|
All Speakers
|
2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
|
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
|
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
|
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
|
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
|
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
|
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
|
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
|
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
|
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
|
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Allucent
Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Submit a Text Ad
|